US Bancorp’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$142K Buy
5,377
+584
+12% +$15.5K ﹤0.01% 2237
2025
Q1
$116K Buy
4,793
+972
+25% +$23.5K ﹤0.01% 2324
2024
Q4
$154K Buy
3,821
+9
+0.2% +$362 ﹤0.01% 2168
2024
Q3
$241K Sell
3,812
-1,206
-24% -$76.4K ﹤0.01% 1937
2024
Q2
$266K Sell
5,018
-1,924
-28% -$102K ﹤0.01% 1843
2024
Q1
$569K Buy
6,942
+4,596
+196% +$377K ﹤0.01% 1423
2023
Q4
$43.7K Buy
2,346
+937
+67% +$17.4K ﹤0.01% 2738
2023
Q3
$15.6K Sell
1,409
-26,981
-95% -$299K ﹤0.01% 2985
2023
Q2
$460K Sell
28,390
-5,879
-17% -$95.3K ﹤0.01% 1433
2023
Q1
$571K Sell
34,269
-4,301
-11% -$71.6K ﹤0.01% 1337
2022
Q4
$363K Buy
+38,570
New +$363K ﹤0.01% 1564
2021
Q4
Sell
-4,662
Closed -$29K 4184
2021
Q3
$29K Sell
4,662
-291
-6% -$1.81K ﹤0.01% 2927
2021
Q2
$30K Sell
4,953
-49
-1% -$297 ﹤0.01% 2920
2021
Q1
$32K Buy
5,002
+3,543
+243% +$22.7K ﹤0.01% 2799
2020
Q4
$8K Sell
1,459
-2,466
-63% -$13.5K ﹤0.01% 3252
2020
Q3
$23K Sell
3,925
-210
-5% -$1.23K ﹤0.01% 2729
2020
Q2
$30K Sell
4,135
-108
-3% -$784 ﹤0.01% 2591
2020
Q1
$20K Buy
4,243
+210
+5% +$990 ﹤0.01% 2694
2019
Q4
$32K Buy
4,033
+46
+1% +$365 ﹤0.01% 2663
2019
Q3
$27K Sell
3,987
-108
-3% -$731 ﹤0.01% 2727
2019
Q2
$34K Sell
4,095
-56
-1% -$465 ﹤0.01% 2699
2019
Q1
$41K Buy
+4,151
New +$41K ﹤0.01% 2582